UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype

Scientific reports, 2017-01, Vol.7 (1), p.39011-39011, Article 39011

2017

Volltextzugriff (PDF)

Validating a Selective S1P1 Receptor Modulator Syl930 for Psoriasis Treatment

Biological and Pharmaceutical Bulletin, 2018/04/01, Vol.41(4), pp.592-596

2018

Volltextzugriff (PDF)

Secreted HSP90α-LRP1 Signaling Promotes Tumor Metastasis and Chemoresistance in Pancreatic Cancer

International journal of molecular sciences, 2022-05, Vol.23 (10), p.5532

2022

Volltextzugriff (PDF)

Repressive translational control in germ cells

Molecular reproduction and development, 2013-08, Vol.80 (8), p.665-676

2013

Volltextzugriff (PDF)

Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents

Molecules (Basel, Switzerland), 2019-06, Vol.24 (11), p.2124

2019

Volltextzugriff (PDF)

Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors

Molecules (Basel, Switzerland), 2020-03, Vol.25 (6), p.1447

2020

Volltextzugriff (PDF)

The effect of rapid and delayed insemination on reproductive outcome in conventional insemination and intracytoplasmic sperm injection in vitro fertilization cycles

Journal of assisted reproduction and genetics, 2021-10, Vol.38 (10), p.2697-2706

2021

Volltextzugriff (PDF)

Rutaecarpine suppresses atherosclerosis in ApoE−/− mice through upregulating ABCA1 and SR-BI within RCT[S]

Journal of lipid research, 2014-08, Vol.55 (8), p.1634-1647

2014

Volltextzugriff (PDF)

Repression of zygotic gene expression in the Xenopus germline

Development (Cambridge), 2010-02, Vol.137 (4), p.651-660

2010

Volltextzugriff (PDF)

Development of 3-alkyl-6-methoxy-7-hydroxy-chromones (AMHCs) from natural isoflavones, a new class of fluorescent scaffolds for biological imaging

Chemical communications (Cambridge, England), 2015-01, Vol.51 (5), p.881-884

2015

Volltextzugriff (PDF)

Associations between serum total bilirubin, obesity and type 2 diabetes

Diabetology and metabolic syndrome, 2021-12, Vol.13 (1), p.143-143, Article 143

2021

Volltextzugriff (PDF)

Association between intrahepatic triglyceride content in subjects with metabolically healthy abdominal obesity and risks of pre-diabetes plus diabetes: an observational study

BMJ open, 2022-02, Vol.12 (2), p.e057820-e057820

2022

Volltextzugriff (PDF)

YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer

Acta pharmaceutica Sinica. B, 2022-06, Vol.12 (6), p.2845-2858

2022

Volltextzugriff (PDF)

A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models

Acta pharmaceutica Sinica. B, 2020-02, Vol.10 (2), p.276-288

2020

Volltextzugriff (PDF)

Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection

Acta pharmaceutica Sinica. B, 2023-12, Vol.13 (12), p.4945-4962

2023

Volltextzugriff (PDF)

S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung

Acta pharmaceutica Sinica. B, 2023-03, Vol.13 (3), p.1110-1127

2023

Volltextzugriff (PDF)

Author correction to “YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer” [Acta Pharmaceutica Sinica B 12 (2022) 2845–2858]

Acta pharmaceutica Sinica. B, 2023-07, Vol.13 (7), p.3178-3179

2023

Volltextzugriff (PDF)

Quantitative Evaluation of in Vivo Target Efficacy of Anti-tumor Agents via an Immunofluorescence and EdU Labeling Strategy

Frontiers in pharmacology, 2018-07, Vol.9, p.812-812

2018

Volltextzugriff (PDF)

Sphingosine-1-Phosphate Receptor Subtype 1 (S1P1) Modulator IMMH001 Regulates Adjuvant- and Collagen-Induced Arthritis

Frontiers in pharmacology, 2019-09, Vol.10, p.1085-1085

2019

Volltextzugriff (PDF)

Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults

BMJ open diabetes research & care, 2021-08, Vol.9 (1), p.e002362

2021

Volltextzugriff (PDF)

Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs

Nucleic acids research, 2009-12, Vol.37 (22), p.7560-7569

2009

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors

European journal of medicinal chemistry, 2020-02, Vol.188, p.111985, Article 111985

2020

Volltextzugriff (PDF)

Xenopus Nanos1 is required to prevent endoderm gene expression and apoptosis in primordial germ cells

Development (Cambridge), 2012-04, Vol.139 (8), p.1476-1486

2012

Volltextzugriff (PDF)

Corrigendum to “Novel Nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies” [Eur. J. Med. Chem. 244 (2022) 114832 / EJMECH-D-22-01635R2]

European journal of medicinal chemistry, 2024-10, p.116957, Article 116957

2024

Volltextzugriff (PDF)

Involvement of NADPH oxidases in the Na/K‑ATPase/Src/ROS oxidant amplification loop in renal fibrosis

Molecular medicine reports, 2023-09, Vol.28 (3), Article 161

2023

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(172)

Publikationsform

Sprache

Englisch
(179)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(101)
Humans
(47)
Animals
(32)
Physical Sciences
(29)
Chemistry
(26)
Pharmacology & Pharmacy
(26)
Biochemistry & Molecular Biology
(23)
Mice
(20)
Female
(18)
Male
(17)
Apoptosis
(16)
Technology
(16)
Cell Biology
(15)
Cell Line, Tumor
(14)
Chemistry, Medicinal
(14)
Proteins
(12)
Cell Proliferation
(10)
Chemistry, Multidisciplinary
(10)
Science & Technology - Other Topics
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Chlorogenic acid inhibits glioblastoma growth through repolarizating macrophage from M2 to M1 phenotype

Validating a Selective S1P1 Receptor Modulator Syl930 for Psoriasis Treatment

Secreted HSP90α-LRP1 Signaling Promotes Tumor Metastasis and Chemoresistance in Pancreatic Cancer

Repressive translational control in germ cells

Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents

Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors

The effect of rapid and delayed insemination on reproductive outcome in conventional insemination and intracytoplasmic sperm injection in vitro fertilization cycles

Rutaecarpine suppresses atherosclerosis in ApoE−/− mice through upregulating ABCA1 and SR-BI within RCT[S]

Repression of zygotic gene expression in the Xenopus germline

Development of 3-alkyl-6-methoxy-7-hydroxy-chromones (AMHCs) from natural isoflavones, a new class of fluorescent scaffolds for biological imaging

Associations between serum total bilirubin, obesity and type 2 diabetes

Association between intrahepatic triglyceride content in subjects with metabolically healthy abdominal obesity and risks of pre-diabetes plus diabetes: an observational study

YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer

A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models

Discovery and druggability evaluation of pyrrolamide-type GyrB/ParE inhibitor against drug-resistant bacterial infection

S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung

Author correction to “YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer” [Acta Pharmaceutica Sinica B 12 (2022) 2845–2858]

Quantitative Evaluation of in Vivo Target Efficacy of Anti-tumor Agents via an Immunofluorescence and EdU Labeling Strategy

Sphingosine-1-Phosphate Receptor Subtype 1 (S1P1) Modulator IMMH001 Regulates Adjuvant- and Collagen-Induced Arthritis

Joint associations of metabolically healthy abdominal obesity and non-alcoholic fatty liver disease with prediabetes and diabetes in Chinese adults

Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs

Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors

Xenopus Nanos1 is required to prevent endoderm gene expression and apoptosis in primordial germ cells

Corrigendum to “Novel Nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies” [Eur. J. Med. Chem. 244 (2022) 114832 / EJMECH-D-22-01635R2]

Involvement of NADPH oxidases in the Na/K‑ATPase/Src/ROS oxidant amplification loop in renal fibrosis

Suchergebnisse filtern